Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$81.07 - $121.29 $559,383 - $836,901
-6,900 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $173,383 - $282,812
-1,700 Reduced 19.77%
6,900 $807,000
Q2 2021

Aug 06, 2021

BUY
$141.6 - $179.06 $1.22 Million - $1.54 Million
8,600 New
8,600 $1.42 Million
Q1 2019

May 15, 2019

SELL
$35.52 - $62.62 $362,304 - $638,724
-10,200 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $361,386 - $574,158
10,200 New
10,200 $390,000
Q1 2018

May 15, 2018

SELL
$69.46 - $88.57 $388,975 - $495,991
-5,600 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$65.94 - $93.31 $501,144 - $709,156
-7,600 Reduced 57.58%
5,600 $387,000
Q3 2017

Nov 15, 2017

BUY
$80.87 - $91.08 $1.07 Million - $1.2 Million
13,200
13,200 $1.2 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $153M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.